A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter study

Am J Hematol. 2019 May;94(5):E122-E124. doi: 10.1002/ajh.25426. Epub 2019 Feb 14.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Disease-Free Survival
  • Epstein-Barr Virus Infections* / diagnosis
  • Epstein-Barr Virus Infections* / drug therapy
  • Epstein-Barr Virus Infections* / microbiology
  • Female
  • Follow-Up Studies
  • Herpesvirus 4, Human*
  • Humans
  • Lymphoma, Extranodal NK-T-Cell* / diagnosis
  • Lymphoma, Extranodal NK-T-Cell* / drug therapy
  • Lymphoma, Extranodal NK-T-Cell* / mortality
  • Lymphoma, Extranodal NK-T-Cell* / virology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nose Neoplasms* / diagnosis
  • Nose Neoplasms* / drug therapy
  • Nose Neoplasms* / mortality
  • Nose Neoplasms* / virology
  • Prognosis
  • Retrospective Studies
  • Survival Rate